Company Update AUROBINDO PHARMA LTD. - 524804 - Completion Of US FDA Inspection At Unit IV Of APL … BSE India The USFDA inspected Unit IV, a formulation manufacturing facility of APL Healthcare Limited, a wholly owned subsidiary of the Company from September 13 to September 19, 2023. At the end of the inspection a Form 483 was issued with one observation which is procedural in nature.